OPKO Connect provides comprehensive support
For patients identified as not having affordable
access to Rayaldee therapy, OPKO offers a
free drug patient assistance program;
eligibility criteria apply and annual
re-enrollment is required.
With this program, eligible
commercially insured patients can fill
their Rayaldee prescription for no more
than $5 per month until the annual
maximum limit is reached.
Starter dose program
This program provides a one-time-only free,
14-day supply of product to eligible patients
whose initial Rayaldee coverage determination
is delayed more than 5 days based on payer
Prior authorization support
Can assist with any insurer-required PAs
for Rayaldee on behalf of patients.